INCY Incyte Genomics Inc

Sentiment & Price 2 ideas • 1 voices • 1 sources ▼
Sentiment Gauge
0
Bull
0
Bear
0
Watch
Bull 50% Bear 50%
Price & Sentiment
Loading chart...
Recent News Top Views ▼
No recent news for INCY
No theses available
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
News✓
Loading...
All directions✓
▲ Long✓
▼ Short✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
01:10
Mar 08
@seekingalpha
The failure to win a key FDA label expansion is a direct negative catalyst for the stock, impacting future revenue streams.
INCY
MED
08:24
Feb 20
@seekingalpha
The trade is long Incyte based on the continued strength of its ruxolitinib franchise and strong expected sales growth for its drug Opzelura.
INCY
MED

About INCY Analyst Coverage

Buzzberg tracks INCY (Incyte Genomics Inc) across 1 sources. 1 bullish vs 1 bearish calls from 1 analysts. Sentiment: evenly split. 2 total trade ideas tracked.